This website is intended for healthcare professionals only.
Newsletter
Search for:
News
Covid-19
Insight and Analysis
Healthcare data
Reports
Clinical
Allergy
Cardiovascular
Emergency and critical care
Oncology/Haematology
Gastroenterology
Radiology and Imaging
Respiratory
Rheumatology
Educational resources
Issues
2021
2020
2019
2018
2017
2016
Sponsored
Search for:
News
Covid-19
Insight and Analysis
Healthcare data
Reports
Clinical
Allergy
Cardiovascular
Emergency and critical care
Oncology/Haematology
Gastroenterology
Radiology and Imaging
Respiratory
Rheumatology
Educational resources
Issues
2021
2020
2019
2018
2017
2016
Sponsored
Clinical
Suicidal thought related to pain in one in ten patients with rheumatic or musculoskeletal disease
Significant gaps in essential RA care across Europe and between European countries revealed
EULAR launches Time2Work campaign
No link between cancer and TNF inhibitor use in psoriatic arthritis
New biomarkers for cardiovascular risk in juvenile-onset SLE
Study debunks theoretical risks of live-attenuated vaccines in paediatric rheumatic disease
Scotland sees advance in treatment of kidney cancer
Phase IIIa clinical trial data presented for oral semaglutide
Protons to play a vital role in the battle against prostate cancer
Research finds that high fibre during pregnancy reduces risk of coeliac disease in children
Omalizumab significantly reduced nasal polyps and congestion in chronic rhinosinusitis
Long-term data from pivotal Phase III studies of ibrutinib presented at ASCO and EHA
Page 71 of 172
« First
«
...
10
20
30
...
69
70
71
72
73
...
80
90
100
...
»
Last »
Popular articles
Shorter tuberculosis treatment strategy non-inferior to standard regimen
20 March, 2023
Prostate cancer mortality no different in trial of three treatment interventions
21 March, 2023
High-sensitivity CRP superior to LDL cholesterol for CV event and mortality risk prediction
21 March, 2023
Higher plasma caffeine levels linked to reduced body fat and type 2 diabetes risk according to genetic study
23 March, 2023
Ide-cel provides 51% reduction in the risk of progression or death in R/R multiple myeloma
23 March, 2023